FDA Announces WHO Cooperative Agreement to Combat False Medicines
The Food and Drug Administration is announcing its intention to accept and consider a single source application for award of a cooperative agreement to the World Health Organization (WHO) in support of building a global surveillance and monitoring system for…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
combating counterfeit/falsified medicines and risks and breaches in the supply. The support will be one year with the possibility of an additional three years.